Safety of urgent surgery for the patients with proximal femur fracture treated with platelet aggregation inhibitors: a propensity-score matching analysis
- Authors
- Kim, Chul-Ho; Chang, Jae Suk; Lim, Yaeji; Lim, Dongkyung; Kim, Ji Wan
- Issue Date
- Apr-2024
- Publisher
- Springer Science and Business Media Deutschland GmbH
- Keywords
- Delay; Platelet aggregation inhibitors; Proximal femur fracture
- Citation
- European Journal of Trauma and Emergency Surgery, v.50, no.2, pp 347 - 358
- Pages
- 12
- Journal Title
- European Journal of Trauma and Emergency Surgery
- Volume
- 50
- Number
- 2
- Start Page
- 347
- End Page
- 358
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/68360
- DOI
- 10.1007/s00068-023-02368-9
- ISSN
- 1863-9933
1863-9941
- Abstract
- Introduction: To compare the various perioperative outcomes in an urgent surgery setting among patients with proximal femur fracture (PFF) who received platelet aggregation inhibitors (PAIs) and those who did not. Methods: We retrospectively reviewed the data of 1,838 patients who underwent surgery for PFF between January 2011 and January 2021. We conducted 1:1 propensity-score matching and compared the perioperative outcomes, including operation time, postoperative complications, hospital stay, mortality, and variables related to bleeding risk (e.g., number of transfusion profiles, hemoglobin levels, and laboratory data, including coagulation battery). Results: Of the 492 patients who were treated with PAIs, 484 were 1:1 matched to the untreated control group. The PAI group showed shorter operation time than the matched control group (72.3 min for PAI vs. 77.7 min for control; P = 0.041), and the control group showed more pulmonary thromboembolism (0.2% for PAI vs 1.7% for control; P = 0.046) than the PAI group. The other complications and length of hospital stay, mortality rate, transfusion profile, and the laboratory test (except preoperative international normalized ratio, INR) showed no significant difference between the groups. Subgroup analyses of the patients treated with only aspirin (aspirin: 306, matched control: 306), only clopidogrel (clopidogrel: 100, matched control: 100), and others who were treated with dual anticoagulation (dual anticoagulation: 78, matched control: 78) showed no significant differences in perioperative outcomes among the groups. Conclusion: The patients who were treated with PAI could undergo PFF surgery safely without delay, which led to no significant difference in operation time, postoperative complication risk, perioperative blood transfusion, and variables related to bleeding risk. Therefore, we believe that it is unnecessary to delay surgery for patients with PFF who receive PAI. © 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/68360)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.